Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Catalytic Glycosylation. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN118373865B details a high-yield nucleoside intermediate route offering significant cost reduction and supply chain reliability for pharmaceutical manufacturing.
Patent CN114891049A reveals a stable glycosylation method enabling rapid oligosaccharide synthesis with high yields and simplified purification for reliable pharmaceutical intermediates supplier.
Patent CN112028947B reveals a novel alkaline synthesis for Tribenoside, eliminating genotoxic impurities and ensuring high purity for reliable pharmaceutical intermediate supply chains.
Novel catalytic glycosylation for Doxifluridine reduces Lewis acid usage and improves yield to 98%. A reliable API intermediate supplier for cost reduction.
Patent CN112159447B details a novel DMAP-catalyzed route for 2-chloroadenosine, offering superior purity and yield while eliminating heavy metal contamination for scalable API production.
Patent CN106279311B details a novel Gastrodin synthesis using montmorillonite and ceric ammonium nitrate, offering significant cost reduction and supply chain reliability for pharmaceutical manufacturers.
Advanced synthesis of Garcinoside via mild catalytic esterification and deacetylation. Eliminates silica gel columns for high-purity, scalable manufacturing.